ViaCyte
0 Followers
About
ViaCyte is a regenerative medicine company focused on the discovery, development & commercialization of novel cell replacement therapies to treat diabetes.
- Website
- Headquarters
- Industry
- Social
Team
View all (22)
Michael Yang
CEO, President
Brittany K. Bradrick
CFO
Kevin D’amour
VP, Research & Chief Scientific Officer
Howard Foyt
Chief Medical Officer
Steve White
Chief Technology Officer
Liz Bui
VP, Intellectual Property and Counsel & Diversity & Inclusion Officer
Manasi Sinha Jaiman
VP, Clinical Development
Steve Kradjian
VP, Regulatory
Anne Sandan
Vice President, Finance
Ian F. Smith
Executive Chairperson
Fred A. Middleton
Director
Steven R. Altman
Director
Jobs
View all (0)No jobs yet!
Wires
View all (0)No wires yet!
By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.